Metabolic driver of Parkinson’s disease offers new target for treatment

Researchers have identified a key enzyme driving forms of Parkinson’s disease, and have shown how blocking it restores normal function in animal and cell models, offering a promising new drug target for the condition.

Leave A Comment

Your email address will not be published. Required fields are marked *